Periostin: novel diagnostic and therapeutic target for cancer.
Open accessThe DOI matches its OpenAlex record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Periostin is a secreted protein that shares a structural homology to the axon guidance protein fasciclin I (FAS1) in insects and was originally named as osteoblast-specific factor-2 (Osf2). Periostin is particularly highly homologus to Betaig-h3, which promotes cell adhesion and spreading of fibroblasts. It has recently been reported that Periostin was frequently overexpressed in various types of human cancers. Although the detailed function of Periostin is still unclear, Periostin-integrin interaction through FAS1 domain is thought to be involved in tumor development. In addition, Periostin stimulates metastatic growth by promoting cancer cell survival, invasion and angiogenesis. Therefore, Periostin can be a useful marker to predict the behavior of cancer. This review summarizes the recent understanding of Periostin roles in tumor development and speculates on the usefulness of Periostin as a therapeutic and diagnostic target for cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kim, K. J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H. S., & Ferrara, N. (1993) · Nature · doi:10.1038/362841a0 · Cited by 3,605
Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
Brooks, P. C., Montgomery, A. M. P., Rosenfeld, M., Reisfeld, R. A., Hu, T., Klier, G., & Cheresh, D. A. (1994) · Cell · doi:10.1016/0092-8674(94)90007-8 · Cited by 2,262 · cited 2×
“Both αvß3 integrins and Akt/PKB pathway have been implicated as playing important roles in promoting cell survival and tumorigenesis (Brooks et al., 1994; Nicholson and Anderson, 2002; Stupack and Cheresh, 2002).”
Background
Cited by
Sidhu, S. S., Yuan, S., Innes, A. L., Kerr, S., Woodruff, P. G., Hou, L., Muller, S. J., & Fahy, J. V. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009426107 · Cited by 384
The multifaceted role of periostin in tumorigenesis
Ruan, K., Bao, S., & Ouyang, G. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0013-7 · Cited by 326
Targeted Gene Silencing Using RGD-Labeled Chitosan Nanoparticles
Han, H. D., Mangala, L. S., Lee, J. W., Shahzad, M. M. K., Kim, H. S., Shen, D., Nam, E. J., Mora, E. M., Stone, R. L., Lu, C., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0005 · Cited by 282
Periostin expression and epithelial-mesenchymal transition in cancer: a review and an update
Morra, L., & Moch, H. (2011) · Virchows Archiv · doi:10.1007/s00428-011-1151-5 · Cited by 256
Endometrial gene expression in early pregnancy: Lessons from human ectopic pregnancy
Savaris, R. F., Hamilton, A. E., Lessey, B. A., & Giudice, L. C. (2008) · Reproductive Sciences · doi:10.1177/1933719108317585 · Cited by 37
Metadata
- Authors
- Kudo, Y., Siriwardena, B. S. M. S., Hatano, H., Ogawa, I., & Takata, T.
- Venue
- PubMed
- Publisher
- National Institutes of Health
- Published
- 2007-10-01
- Volume
- 22
- Issue
- 10
- Pages
- 1167-74
- OpenAlex
- W9306304
- Cited by
- 166
- References
- 2
- FWCI
- 8.89
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.